Home/ Supplements/ Electrolytes/ MigreLief-NOW

MigreLief-NOW

product on market Capsule Akeso Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 75% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Magnesium, feverfew, ginger, and boswellia serrata are utilized for their potential to reduce migraine frequency and intensity. Research provides moderate evidence for the efficacy of magnesium and feverfew in headache prophylaxis. However, overall evidence coverage for this specific combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for MigreLief-NOW
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
Botanical with Nutrients
Product Type
75%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

180 mg (45% DV)
Within RDA (0.4× RDA) 316 studies (A:8, B:159)
Market median: 380.0mg (120 products) 8 studies — no high-quality reviews
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)
Market median: 375.0mg (171 products) 31 studies (A:1, B:14)

Other Ingredients

powdered Cellulose Grape seed extract Silicon Dioxide Magnesium Stearate Vegetable Capsule Hydroxpropyl Methylcellulose Titanium Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Usage: Age 14-Adult: Take 3-4 capsules with food. May repeat dose in 2 hrs. (Do not exceed 8 capsules in a 24 hr. period or 4 if combining with a MigreLief daily formula.)

Age 9-13: 1-2 capsules with food. May repeat dose in 2 hrs. (Do not exceed 4 capsules in a 24 hr. period or 2 if combining with a MigreLief daily formula.)

Age 2-8: 1 capsule with food. May repeat dose in 2 hrs. (Do not exceed 2 capsules in a 24 hr. period.)

Warnings & Precautions

(Do not exceed 8 capsules in a 24 hr. period or 4 if combining with a MigreLief daily formula.)

(Do not exceed 4 capsules in a 24 hr. period or 2 if combining with a MigreLief daily formula.)

(Do not exceed 2 capsules in a 24 hr. period.)

Warnings: Not for use during pregnancy, lactation or by children under age 2.

Warnings: Not for use during pregnancy, lactation or by children under age 2.

Formulation Notes

Does not contain: Aspirin, caffeine, yeast, milk, corn, wheat, gluten, soy, salt, artificial colorings or flavorings.

Triple benefits from Cerevasc, Puracol & Aflapin

Puracol is a proprietary combination of whole leaf feverfew that contains a broad sprectrum of naturally occurring phytochemicals and a unique feverfew extract.

Cerevasc Ginger is a proprietary combination of ginger rhizome powder and standardized ginger extract.

Additional Information

MigreLief-NOW can be taken as needed for on the spot support of healthy neurological function.

Where nature & medicine unite

As-Needed On the spot nutritional support

MigreLief Formulas are recommended by top headache doctors to provide nutritional support for migraine sufferers

Metadata

Product Details

UPC / SKU8 55586 00082 7
DSLD Entry Date2018-11-21
Product TypeBotanical with Nutrients
FormCapsule
BrandAkeso
DSLD ID183034
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.